Jørgen Jespersen
About
In The Last Decade
Jørgen Jespersen
313 papers receiving 7.6k citations
Peers
Comparison fields: 5 of 156
- Cardiology and Cardiovascular Medicine 2.6k
- Hematology 1.9k
- Pulmonary and Respiratory Medicine 1.6k
- Internal Medicine 1.5k
- Endocrinology, Diabetes and Metabolism 1.3k
Countries citing papers authored by Jørgen Jespersen
This map shows the geographic impact of Jørgen Jespersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørgen Jespersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørgen Jespersen more than expected).
Fields of papers citing papers by Jørgen Jespersen
This network shows the impact of papers produced by Jørgen Jespersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørgen Jespersen. The network helps show where Jørgen Jespersen may publish in the future.
Co-authorship network of co-authors of Jørgen Jespersen
This figure shows the co-authorship network connecting the top 25 collaborators of Jørgen Jespersen. A scholar is included among the top collaborators of Jørgen Jespersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørgen Jespersen. Jørgen Jespersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 17 | |
| 4 | 19 | |
| 5 | 19 | |
| 6 | 2 | |
| 7 | 34 | |
| 8 | An assessment of a method for ISI calibration of two whole blood point-of-care PT monitor systems based on lyophilised plasmas using whole blood equivalent PT | 3 |
| 9 | An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors | 6 |
| 10 | 28 | |
| 11 | Hormone replacement therapy - estrogen and progestin effects on plasma C-reactive protein. | 2 |
| 12 | Diabetes as a procoagulant condition | 3 |
| 13 | PROPOSAL FOR A GENERAL STRATEGY OF STANDARDIZATION OF FIBRINOLYSIS ASSAYS TO BE USED IN CLINICAL PRACTICE | 4 |
| 14 | [Food intake of Danes and cardiac risk factors]. | 3 |
| 15 | HOW TO DETECT DEFECTS OF TISSUE PLASMINOGEN ACTIVATOR IN THROMBOSIS-PRONE PATIENTS. AN INTRODUCTION TO DISCUSSION | 3 |
| 16 | 8 | |
| 17 | Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis. | 2 |
| 18 | Thrombosis, disseminated intravasclar coagulation, and the dynamic haemostatic balance. Aspects of prophylaxis and treatment | 3 |
| 19 | 17 | |
| 20 | [Salicylate hepatitis in rheumatic fever]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.